ArticleMedicine2026
Efficacy of acupotomy in chronic pharyngitis: A retrospective analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to evaluate the efficacy and complications of acupotomy in chronic pharyngitis. We reviewed the medical records of patients who received acupotomy for chronic pharyngitis in the Traditional Chinese Medicine Department between January 2023 and December 2024, comparing symptom and sign scores before and after treatment. A reduction of ≥30% in symptom/sign scores after treatment was defined as effective. Treatment-related complications were also observed. One month after 3 sessions of treatment, scores for pharyngeal dryness (median difference [MD] = -0.58, 95% confidence interval [CI -0.76 to -0.40], P < .01), pharyngeal itching (MD = -3.06, 95% CI [-4.01 to -2.11], P < .01), pharyngeal pain (MD = -1.06, 95% CI [-1.28 to -0.84], P < .01), pharyngeal foreign-body sensation (MD = -2.39, 95% CI [-2.65 to -2.13], P < .01), pharyngeal adhesiveness (MD = -1.18, 95% CI [-1.41 to -0.95], P < .01) and cough (MD = -2.10, 95% CI [-2.38 to -1.82], P < .01) were significantly lower than before treatment. A month after the third session, scores for pharyngeal mucosal congestion (MD = -1.27, 95% CI [-1.48 to -1.06], P < .01), pharyngeal lymphoid follicular hyperplasia (MD = -1.07, 95% CI [-1.28 to -0.86], P < .01), pharyngeal mucosal hypertrophy and hyperplasia (MD = -0.54, 95% CI [-0.73 to -0.35], P < .05) and hypertrophy and swelling of the pharyngeal lateral cord (MD = -0.46, 95% CI [-0.64 to -0.28], P < .05) were also significantly reduced compared to before treatment. Acupotomy was associated with symptomatic improvement in this cohort. However, due to the study's limitations and small sample size, no definitive conclusions can be drawn. Well-designed prospective studies with larger samples, multicenter, controlled studies are needed to confirm efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.